Medicare Enrolled

Dr. Elizabeth Odstrcil, M.D.

Gastroenterology · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3417 GASTON AVENUE, Dallas, TX 75246
2148215266
In practice since 2007 (18 years)
NPI: 1164623351 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Odstrcil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Odstrcil? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Odstrcil

Dr. Elizabeth Odstrcil is a gastroenterology in Dallas, TX, with 18 years in practice. Based on federal Medicare data, Dr. Odstrcil performed 804 Medicare services across 751 unique beneficiaries.

Between the years covered by Open Payments, Dr. Odstrcil received a total of $23,042 from 46 pharmaceutical and/or device companies across 972 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Odstrcil is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 34% volume in TX$ $23,042 industry payments

Medicare Practice Summary

Medicare Utilization ↗
804
Medicare services
Top 34% in TX for gastroenterology
751
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~45 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Upper GI endoscopy with biopsy144$58$680
Colonoscopy with biopsy127$108$847
Office visit, established patient (30-39 min)100$86$217
Removal of polyps or growths of large bowel using an endoscope with mechanical snare91$202$1,067
Office visit, established patient (20-29 min)84$57$148
Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm42$94$649
New patient office visit (45-59 min)37$106$332
Initial hospital admission, moderate complexity37$102$278
Hospital follow-up visit, low complexity37$39$80
Colorectal cancer screening; colonoscopy on individual at high risk32$179$778
Other procedure on small bowel16$226$1,000
Diagnostic exam of large bowel using a flexible endoscope16$132$781
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk16$179$781
New patient office visit (30-44 min)14$82$219
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope11$65$518
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,042
Total received (2018-2024)
Avg $3,292/year across 7 years
Top 10% in TX for gastroenterology
46
Companies
972
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,375 (71.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,181 (26.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$486 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,559
2023
$3,263
2022
$2,910
2021
$2,294
2020
$1,559
2019
$7,707
2018
$1,751

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Olympus Corporation of the Americas
$6,181
ABBVIE INC.
$4,107
AbbVie Inc.
$1,779
Celgene Corporation
$1,629
Takeda Pharmaceuticals U.S.A., Inc.
$1,596
Janssen Biotech, Inc.
$1,082
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$997
AbbVie, Inc.
$894
QOL Medical, LLC
$720
Ferring Pharmaceuticals Inc.
$493
Merck Sharp & Dohme LLC
$397
Allergan Inc.
$334
GENZYME CORPORATION
$317
Regeneron Healthcare Solutions, Inc.
$307
INTERCEPT PHARMACEUTICALS, INC.
$177
Synergy Pharmaceuticals Inc
$169
BOSTON SCIENTIFIC CORPORATION
$166
PFIZER INC.
$166
Covidien LP
$137
Braintree Laboratories, Inc.
$136
RedHill Biopharma Inc.
$122
AIMMUNE THERAPEUTICS, INC.
$118
Ironwood Pharmaceuticals, Inc
$112
Merck Sharp & Dohme Corporation
$100
SHIELD THERAPEUTICS INC
$97
Nestle HealthCare Nutrition Inc.
$91
Shire North American Group Inc
$85
UCB, Inc.
$72
Boston Scientific Corporation
$59
Daiichi Sankyo Inc.
$48
Shionogi Inc
$39
Micro-tech Endoscopy USA, Inc.
$33
Allergan, Inc.
$33
NESTLE HEALTHCARE NUTRITION INC.
$31
Lilly USA, LLC
$26
Amgen Inc.
$25
Madrigal Pharmaceuticals
$24
Ipsen Biopharmaceuticals, Inc
$20
Intercept Pharmaceuticals, Inc.
$20
Medtronic, Inc.
$18
Concordia Pharmaceuticals Inc.
$17
Ardelyx, Inc.
$16
Evoke Pharma, Inc.
$16
Enterra Medical, Inc.
$15
EVOKE PHARMA, INC.
$11
Romark Laboratories, LC
$9
Top 3 companies account for 52.4% of total payments
Associated products mentioned in payments ›
ACCRUFER · AMJEVITA · APRISO · Alinia Tablets 500mg 30 count bottle · All Products · Amitiza · Beacon · Bylvay · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Donnatal · ENTYVIO · EOHILIA · EXALT Model D · Entyvio · GATTEX · GENERAL - THERAPIES · GI GENIUS · GIMOTI · HUMIRA · Humira · IBSRELA · INJECTAFER · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Motegrity · Mulpleta · OCALIVA · OMVOH · PLENVU · PillCam · REBYOTA · REMICADE · RESMETIROM · RESOLUTION CLIP · RINVOQ · RiteClip · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS TABLETS · VELSIPITY · VIBERZI · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (71%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for gastroenterology in TX.

Equivalent to $2,866 per 100 Medicare services performed
Looking for a gastroenterology in Dallas?
Compare gastroenterologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
242
Per 100K population
9.3
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Odstrcil is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 10%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Odstrcil experienced with upper gi endoscopy with biopsy?
Based on Medicare claims data, Dr. Odstrcil performed 144 upper gi endoscopy with biopsy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Odstrcil receive payments from pharmaceutical companies?
Yes. Dr. Odstrcil received a total of $23,042 from 46 companies across 972 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Odstrcil's costs compare to other gastroenterologys in Dallas?
Dr. Odstrcil's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Odstrcil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →